Please assess the completion status of the following clinical trial:

Trial Title: Vitamin D3 Treatment and Homocysteine Concentrations Among Overweight Reproductive Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Overweight (BMI between 25-29.99 kg/m2)~* Had 25(OH)D \< 20 ng/mL~* Had normal vitamin B-12 and folic acid levels~* Not diagnosed with any chronic diseases~* Agreed to participat in the study~Exclusion Criteria:~* age \< 18 or \> 49 years~* BMI \> 30 kg/m2 or \< 25 kg/m2~* 25 (OH)D level \> 20 ng/ml~* tHcy levels greater than 100 µmol/L~* Abnormal vitamin B-12 or folic acid levels~* Chronic diseases~* Pregnant or lactating

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- vitamin D3 (Type: ACTIVE_COMPARATOR): 50,000 IU
- Placebo (Type: PLACEBO_COMPARATOR): Similar in size, shape and color to vitamin D3

Based on this trial design, predict the completion outcome and termination type (if applicable).